NEW YORK, July 27 - Oxford Glycosciences described its proteomics strategy in detail for the first time Friday, laying out the company's technology for cataloging and analyzing proteins to investors and the media at a luncheon in New York.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.